10:26 AM EDT, 03/14/2024 (MT Newswires) -- Bruce Booth, Director, on March 11, 2024, sold 353,357 shares in Kymera Therapeutics ( KYMR ) for $14,912,376. Following the Form 4 filing with the SEC, Booth has control over a total of 828,830 shares of the company, with 828,830 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1815442/000141588924007890/xslF345X03/form4-03132024_110328.xml

Price: 41.10, Change: -1.20, Percent Change: -2.84